VC firm
120 Capital
- Investor type
- VC
- Investing status
- Activeas of 2026-09-28
- Headquarters
- Boston, MA, United States
- Assets under management
- $229MForm ADV private fund GAV, as of 2026-03-30Source (opens in a new tab)
- Funds
- 1
- Legal name
- 120 CAPITAL, LLC
Claim, correct or request removal
Record updated 30 September 2026
About
120 Capital is a life science and healthcare venture fund (tagline: "Powerful Science. Visionary Entrepreneurs. Extraordinary Companies.") reporting B+ AUM, 80+ investments, and 10+ years of history. Its Portfolio News section shows a recurring focus on bringing biotech/medtech assets into Greater China through licensing and joint-venture deals with its portfolio companies. The firm has offices on the US East Coast (Boston, MA) and West Coast (San Francisco, CA).
Investment approach
- Thesis
- POWERFUL SCIENCE VISIONARY ENTREPRENEURS EXTRAORDINARY COMPANIESSource (opens in a new tab)
- Investing status notes
- Portfolio News section includes a Nov 17, 2025 item ("Our Portfolio Company Halda Therapeutics to be Acquired by Johnson & Johnson for $3.05B USD"), i.e. current activity.
Funds
- 120 CAPITAL, L.P.
- Main fund
SEC registration
- Registered adviser
- 120 CAPITAL, LLC
- CRD number
- 319547 (opens in a new tab)
- SEC file number
- 802-124806
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $229Mas of 2026-03-30
- Private funds reported
- 1
- Principal office
- BOSTON, MA, United States
Locations
- Headquarters
- Boston, MA, United States
- Office
- San Francisco, CA, United States
Loading relationship preview